Skip to content

A Comparative Clinical Study of Krakashdaladi Kwath and Navaka Guggulu in the management of Medodushti with special reference to Dyslipidemia

An Open Labelled Parallel Comparative Clinical Study to evaluate the efficacy of Krakashdaladi Kwath and Navaka Guggulu in the management of Medodushti with special reference to Dyslipidemia - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070151
Enrollment
60
Registered
2024-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Institute For Ayurved Studies and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients willing to sign the consent form.2.Patients between the age group of 25-45 years of either gender.3.Patients having underweight, normal weight, overweight, and class I obesity according to BMI.4.Diagnosed & confirmed cases of Medodushti (Dyslipidemia) & Medoroga on the basis of criteria given by NCEP-ATPIII. (Borderline High category).

Exclusion criteria

Exclusion criteria: a) Patient not fulfilling inclusion criteria. b) Patient not willing for clinical trial. c) Patient below 25yrs of age group and above 45yrs of age group. d) Patients having medical history of â?? CAD, CKD, AKD, Uncontrolled Diabetes Mellitus, Uncontrolled Hypertension. e) Patient on steroid therapy and oral contraceptive therapy. f) Pregnant women and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To assess the efficacy of Karkashdaladi kwath and Navak guggulu by applying appropriate stastical tools in the management of dyslipidemia. Timepoint: 28 days

Secondary

MeasureTime frame
1. Reduction in weight, BMI, Serum cholesterol, Serum triglycerides, LDL, VLDL, and an increase in Serum HDL. 2. Reduction in scoring pattern of sign and symptoms of MedorogTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Charu Walia

Institute for Ayurved Studies and Research, SKAU, Kurukshetra

mehranilam@gmail.com9671368058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026